Nitroglycerin 0.4 mg sublingual: Clinical Trials

1 trial of Nitroglycerin 0.4 mg sublingual, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Withdrawn 1

Follow Nitroglycerin 0.4 mg sublingual: new trials by email Literature Review of Nitroglycerin 0.4 mg sublingual trials Research Report on Nitroglycerin 0.4 mg sublingual

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians
Flow Mediated Doppler (FMD), Nitroglycerin 0.4 mg sublingual - Healthy
Not applicableWithdrawnNorthwell Health2010-04-012013-06-12

Sponsors

Northwell Health (1)

Top investigators

Rajiv Jauhar, MD (1)